Clinical Trials for Liver Cancer

5 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
DiagnosticVICCGI1343
02/06/2014
Multi-Parametric 3 Tesla Magnetic Resonance Imaging (MRI) of Response to Transarterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma (HCC)
OtherVICCGI0372
10/01/2003
Outcomes Following Image-Guided Therapy for Hepatic Malignancies.
TreatmentVICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
TreatmentCTSUGI80702-M
05/05/2011
A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or placebo for patients with Resected Stage III Colon Cancer
TreatmentCTSUGIC80802-M
12/07/2010
Phase III randomized study of sorafenib (IND 69896, NSC 724772) plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)

You do not have JavaScript enabled. This site works better with JavaScript turned on.